Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Agilent Joins Picometrics in Biopharma Deal

Apr 2014
SANTA CLARA, Calif. & LABEGE, France, Jan. 21, 2014 — Agilent Technologies Inc. and Picometrics Technologies have signed a co-marketing agreement to improve efficiency in the research and development of complex large-molecule biopharmaceutical compounds.

Analysis technology tools such as capillary electrophoresis (CE), laser-induced fluorescence (LIF) detection and mass spectrometry are particularly useful for the research and development of new biological entities, said Michael Frank, marketing director of liquid phase separations at Agilent.

“As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery,” Frank said.

Several Agilent products can be used with Picometrics’ Zetalif LED and Zetalif Laser instruments, including Agilent’s CE and CE/mass spectrometry technologies, as well as HPLC/UHPLC (high-performance liquid chromatography / ultrahigh-pressure liquid chromatography) solutions.

For more information, visit: or

The study and measurement of spectra and their components.
Agilent TechnologiesAmericasbiopharmaceuticalBiophotonicsBusinessCaliforniaCEEuropeFranceHigh-performance liquid chromatographylasersLiFmarketingMicroscopyRapidScanResearch & TechnologyspectrometryspectroscopyPicometrics Technologiescapillary electrophoresislaser-induced fluorescence detectionZetalif LEDZetalif laserCE/MSHPLC/UHPLCultrahigh-pressure liquid chromatographynew biological entities

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!